Search Results - "Weisel KC"

Isatuximab, carfilzomib, lenalidomide and dexamethasone in newly diagnosed multiple myeloma: a randomized phase 3 trial.

Authors: Gay F Roeloffzen W Dimopoulos MA et al.

Source: Nature medicine [Nat Med] 2026 May; Vol. 32 (5), pp. 1773-1782. Date of Electronic Publication: 2026 Apr 06.

Publication Type: Journal Article; Randomized Controlled Trial; Clinical Trial, Phase III

Journal Info: Publisher: Nature Publishing Company Country of Publication: United States NLM ID: 9502015 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1546-170X (Electronic) Linking ISSN: 10788956 NLM ISO Abbreviation: Nat Med Subsets: MEDLINE

Prospective systematic classification of causes of death in the course of multiple myeloma.

Authors: Jin JX Besemer B Yilmaz B et al.

Source: Blood cancer journal [Blood Cancer J] 2025 Oct 20; Vol. 15 (1), pp. 167. Date of Electronic Publication: 2025 Oct 20.

Publication Type: Letter

Journal Info: Publisher: Nature Pub. Group Country of Publication: United States NLM ID: 101568469 Publication Model: Electronic Cited Medium: Internet ISSN: 2044-5385 (Electronic) Linking ISSN: 20445385 NLM ISO Abbreviation: Blood Cancer J Subsets: MEDLINE; In Process

The evolution to hepta-refractory myeloma involves sequential loss of CD38, BCMA and GPRC5D.

Authors: Riedhammer C Truger M Lee H et al.

Source: Leukemia [Leukemia] 2026 Apr; Vol. 40 (4), pp. 730-738. Date of Electronic Publication: 2026 Feb 17.

Publication Type: Journal Article; Multicenter Study

Journal Info: Publisher: Nature Publishing Group, Specialist Journals Country of Publication: England NLM ID: 8704895 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5551 (Electronic) Linking ISSN: 08876924 NLM ISO Abbreviation: Leukemia Subsets: MEDLINE

Response-adapted lenalidomide-dexamethasone (LenDex) intensification after CyBorD induction for transplant-eligible multiple myeloma: the PIANO study.

Authors: Minakata D Yamamoto G Kako S et al.

Source: Blood research [Blood Res] 2026 Jul 20; Vol. 61 (1). Date of Electronic Publication: 2026 Jul 20.

Publication Type: Journal Article

Journal Info: Publisher: Springer Nature Country of Publication: Switzerland NLM ID: 101605247 Publication Model: Electronic Cited Medium: Print ISSN: 2287-979X (Print) Linking ISSN: 2287979X NLM ISO Abbreviation: Blood Res Subsets: PubMed not MEDLINE

Temporal genomic dynamics shape clinical trajectory in multiple myeloma.

Authors: Maura F Kaddoura M Poos AM et al.

Source: Nature genetics [Nat Genet] 2025 Sep; Vol. 57 (9), pp. 2203-2214. Date of Electronic Publication: 2025 Aug 20.

Publication Type: Journal Article

Journal Info: Publisher: Nature Pub. Co Country of Publication: United States NLM ID: 9216904 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1546-1718 (Electronic) Linking ISSN: 10614036 NLM ISO Abbreviation: Nat Genet Subsets: MEDLINE

Psychological Stress in Breast Cancer Patients during the Course of a Pandemic Disease: Before and after the Availability of Vaccines.

Authors: Schlaiß, Tanja Vassilenko, Mariana Dimova Kimmel, Theresa et al.

Source: Oncology Research & Treatment. 2025, Vol. 48 Issue 12, p804-818. 14p.

Linvoseltamab versus elranatamab for triple-class exposed relapsed or refractory multiple myeloma: an indirect treatment comparison.

Authors: Richter, Joshua Lee, Hans C. Jagannath, Sundar et al.

Source: Leukemia & Lymphoma. Jul2026, p1-13. 13p. 3 Illustrations.

CORRELATION ANALYSIS OF SERUM CCL3, TRACP-5b, AND SCLEROSTIN WITH THE PROGNOSIS OF MULTIPLE MYELOMA PATIENTS.

Alternate Title: ANALIZA KORELACIJE SERUMSKE CCL3, TRACP-5b I SKLEROSTINA SA PROGNOZOM KOD PACIJENATA SA MULTIPLIM MIJELOMOM.

Authors: Jiang, Cuimei Sun, ManMan Gao, Dashan et al.

Source: Journal of Medical Biochemistry. Jun2026, Vol. 45 Issue 6, p1286-1294. 9p.

Real-world outcomes of maintenance therapy post-autologous stem cell transplantation in newly diagnosed multiple myeloma.

Authors: Kang, Ka-Won Kim, Dae Sik Lee, Se Ryeon et al.

Source: BMC Cancer. 2/5/2025, Vol. 25 Issue 1, p1-10. 10p.

Monoclonal gammopathy of clinical significance in a young patient treated with melphalan‐thalidomide‐prednisone.

Authors: Rakotonirainy, Oliva Henintsoa Rakotonirina, Lalao Nomenjanahary Desana, Stevy et al.

Source: Clinical Case Reports. Jun2024, Vol. 12 Issue 6, p1-6. 6p.

MRD contamination in peripheral blood autologous stem cell grafts: implications for relapse and prognosis in multiple myeloma.

Authors: Lin, Jintao He, Jingsong Cai, Zhen et al.

Source: Leukemia & Lymphoma. Feb2026, Vol. 67 Issue 3, p527-535. 9p.

Bortezomib before and after high-dose therapy in transplant-eligible patients with newly diagnosed multiple myeloma: Long-term overall survival after more than 10 years of follow-up from the phase III HOVON-65/GMMG-HD4 trial.

Authors: Mai EK Nogai A Lokhorst HM et al.

Source: HemaSphere [Hemasphere] 2024 Nov 20; Vol. 8 (11), pp. e70052. Date of Electronic Publication: 2024 Nov 20 (Print Publication: 2024).

Publication Type: Journal Article

Journal Info: Publisher: Wiley Country of Publication: United States NLM ID: 101740619 Publication Model: eCollection Cited Medium: Internet ISSN: 2572-9241 (Electronic) Linking ISSN: 25729241 NLM ISO Abbreviation: Hemasphere Subsets: PubMed not MEDLINE

Efficacy and safety of daratumumab, pomalidomide, and dexamethasone versus daratumumab, carfilzomib, and dexamethasone in daratumumab‐naïve relapsed multiple myeloma.

Authors: Dima, Danai Mansour, Razan Davis, James A. et al.

Source: European Journal of Haematology. Jun2024, Vol. 112 Issue 6, p975-983. 9p.

The Evolving Role of Genomic Technologies in Multiple Myeloma: Implications for Diagnosis, Risk Stratification and Resistance.

Authors: Baďurová K Kapustová V Kotulová J et al.

Source: Molecular diagnosis & therapy [Mol Diagn Ther] 2026 May; Vol. 30 (3), pp. 475-494. Date of Electronic Publication: 2026 Mar 30.

Publication Type: Journal Article; Review

Journal Info: Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 101264260 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1179-2000 (Electronic) Linking ISSN: 11771062 NLM ISO Abbreviation: Mol Diagn Ther Subsets: MEDLINE

2025 Update of Cellular Immunotherapy for Plasma Cell Disorders.

Alternate Title: Plazma Hücre Hastalıklarında Hücresel İmmünoterapinin 2025 Güncellemesi.

Authors: Vural, Ece Beksac, Meral

Source: Turkish Journal of Hematology. 2026, Vol. 43 Issue 1, p1-17. 17p.

Pretreatment hemoglobin, myeloma subtype, and induction regimens as independent prognostic factors for survival after autologous stem cell transplantation in multiple myeloma: a retrospective cohort study.

Authors: Zhang, Yong Yang, Guangzhong Gao, Wen et al.

Source: Hematology. Dec2025, Vol. 30 Issue 1, p1-9. 9p.

Efficacy of daratumumab on multiple myeloma patients with renal insufficiency: a systematic review and meta-analysis.

Authors: Jiang, Hua Li, Lu Guo, Meiyu et al.

Source: Hematology. Dec2024, Vol. 29 Issue 1, p1-13. 13p.

Elotuzumab, lenalidomide, bortezomib, dexamethasone, and autologous haematopoietic stem-cell transplantation for newly diagnosed multiple myeloma (GMMG-HD6): results from a randomised, phase 3 trial.

Authors: Mai EK Goldschmid H Miah K et al.

Corporate Authors: Mai EK Goldschmid H Miah K et al.

Source: The Lancet. Haematology [Lancet Haematol] 2024 Feb; Vol. 11 (2), pp. e101-e113.

Publication Type: Randomized Controlled Trial; Clinical Trial, Phase III; Journal Article

Journal Info: Publisher: Elsevier Ltd Country of Publication: England NLM ID: 101643584 Publication Model: Print Cited Medium: Internet ISSN: 2352-3026 (Electronic) Linking ISSN: 23523026 NLM ISO Abbreviation: Lancet Haematol Subsets: MEDLINE

This result is not displayed to guests.
Login for full access.

Hematopoietic stem cells and HSCs-derived from pluripotent stem cells: a hopeful outlook in cell-based therapeutics.

Authors: Khaseb S Karimi R Tavangar F et al.

Source: Molecular biology reports [Mol Biol Rep] 2025 Jun 30; Vol. 52 (1), pp. 657. Date of Electronic Publication: 2025 Jun 30.

Publication Type: Journal Article; Review

Journal Info: Publisher: Reidel Country of Publication: Netherlands NLM ID: 0403234 Publication Model: Electronic Cited Medium: Internet ISSN: 1573-4978 (Electronic) Linking ISSN: 03014851 NLM ISO Abbreviation: Mol Biol Rep Subsets: MEDLINE